Retinoic acid activates human secretin gene expression by Sp proteins and Nuclear Factor I in neuronal SH-SY5Y cells

被引:14
作者
Lee, LTO
Tan-Un, KC
Lin, MCM
Chow, BKC
机构
[1] Univ Hong Kong, Dept Zool, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Inst Mol Biol, Hong Kong, Hong Kong, Peoples R China
关键词
gene regulation; Nuclear Factor I; retinoic acid; secretin; human neuroblastoma cell; SH-SY5Y; Sp1;
D O I
10.1111/j.1471-4159.2005.03018.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Secretin is a neuropeptide that is expressed in distinct central neurones. As there is no information on how the secretin gene is regulated in neuronal cells, a well established neuronal differentiation cell model, SH-SY5Y, was used to study transcriptional regulation of the human secretin gene. High secretin transcript and peptide levels were found in this cell, and secretin gene expression and promoter activity were up-regulated upon all-trans retinoic acid (RA) treatment. Within the promoter, a functional GC-box 1 (-131 from ATG, relative to the ATG initiation codon) was found to be regulated by a brain-specific Sp protein, Sp4, and ubiquitous factors Sp1 and Sp3. The human secretin gene in SH-SY5Y cells is controlled by the (Sp1 + Sp4)/Sp3 ratio and the RA-induced activation is a partial result of a decrease in Sp3 levels. In addition to the GC-box 1, an N1 motif in close proximity was also responsible for RA-induced secretin gene activation. Competitive gel mobility shift and southwestern blot studies revealed binding of Nuclear Factor I (NFI) with the N1 motif. Overexpression of NFI-C increased promoter activity upon RA treatment. Consistent with this observation, NFI-C transcript levels were augmented after RA treatment. We conclude that RA induction of the secretin gene in neuronal cells is regulated by the combined actions of reducing Sp3 and increasing NFI-C expression.
引用
收藏
页码:339 / 350
页数:12
相关论文
共 47 条
[1]   Casein kinase II-mediated phosphorylation of the C terminus of spl decreases its DNA binding activity [J].
Armstrong, SA ;
Barry, DA ;
Leggett, RW ;
Mueller, CR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (21) :13489-13495
[2]  
Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P325
[3]   Regulation of brain fatty acid-binding protein expression by differential phosphorylation of nuclear factor I in malignant glioma cell lines [J].
Bisgrove, DA ;
Monckton, EA ;
Packer, M ;
Godbout, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) :30668-30676
[4]   EARLY ACTIVATION OF ENDOGENOUS PP60SRC KINASE-ACTIVITY DURING NEURONAL DIFFERENTIATION OF CULTURED HUMAN NEUROBLASTOMA-CELLS [J].
BJELFMAN, C ;
MEYERSON, G ;
CARTWRIGHT, CA ;
MELLSTROM, K ;
HAMMERLING, U ;
PAHLMAN, S .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (01) :361-370
[5]   Nuclear factor I-mediated repression of the mouse mammary tumor virus promoter is abrogated by the coactivators p300/CBP and SRC-1 [J].
Chaudhry, AZ ;
Vitullo, AD ;
Gronostajski, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7072-7081
[6]   Characterization of a new upstream GnRH receptor promoter in human ovarian granulosa-luteal cells [J].
Cheng, CK ;
Yeung, CM ;
Chow, BKC ;
Leung, PCK .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (07) :1552-1564
[7]   CLONING OF AN INTRINSIC HUMAN TFIID SUBUNIT THAT INTERACTS WITH MULTIPLE TRANSCRIPTIONAL ACTIVATORS [J].
CHIANG, CM ;
ROEDER, RG .
SCIENCE, 1995, 267 (5197) :531-536
[8]  
CHOW BKC, 1991, J BIOL CHEM, V266, P18927
[9]   The transcription factor nuclear factor I mediates repression of the GLUT4 promoter by insulin [J].
Cooke, DW ;
Lane, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12917-12924
[10]   Children with autistic spectrum disorders. II: Parents are unable to distinguish secretin from placebo under double-blind conditions [J].
Coplan, J ;
Souders, MC ;
Mulberg, AE ;
Belchic, JK ;
Wray, J ;
Jawad, AF ;
Gallagher, PR ;
Mitchell, R ;
Gerdes, M ;
Levy, SE .
ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (08) :737-739